Policy & Regulation
FDA Chooses Dexcom to Pioneer New Regulatory Pathway for AI-Powered Diabetes Tools
The continuous glucose monitoring leader becomes the first company selected for an FDA digital health pilot that could reshape how AI-driven medical devices reach patients.
Health AI Central Editorial Team·July 28, 2026
Digital Health & Wearables
Dexcom Stelo OTC Continuous Glucose Monitor Reaches One Million Users
Dexcom has announced that its Stelo continuous glucose monitor — the first OTC CGM approved by the FDA — has reached one million users, with the majority being people without diabetes who are using the device for metabolic health optimization.
Health AI Central Editorial Team·April 18, 2026